Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company"). On ...

1,600 metres planned for the first drilling campaign on Murphy Lake North since 2005 ... the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the ...

Our training sessions thoroughly cover the Nasdaq Nordic rulebook and Nasdaq First North Growth Market rulebook. The sessions are created for board members, senior management, and auditors of ...

Queen Anne marked her North American debut as she arrived in New York on her maiden call from Southampton, England. Cunard's first new ship in 14 years spans 14 decks and features 15 dining venues ...

Signing a cooperation agreement with InMotion Entertainment Group significantly increases the retail presence of UCLOUDLINK's GlocalMe products across 120+ airport locations in North America.

The deal is anticipated to conclude in the first quarter of 2025 ... The natural gas gathering and processing system in North Dakota shall be integrated into the existing Hiland infrastructure ...

As a result, District's depositary receipts (the "DMX SDRs") will begin trading on Nasdaq First North at market open (Sweden local time) on January 23, 2025, under the symbol "DMXSE SDB".

First Helium Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest ...

Vancouver, British Columbia--(Newsfile Corp. - January 22, 2025) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to announce that the Company ...

Nasdaq First North Growth Market is a registered growth market for small and medium-sized companies in accordance with Directive 2014/65/EU on markets in financial instruments, as implemented in ...

Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that half of the patients in the ongoing Phase III study for the drug candidate AKP02G2 ...